Guaifenesin And Codeine Phosphate Solution
NDC Package 55154-5791-5
Package Information
Guaifenesin And Codeine Phosphate solution is •take every 4 hours•do not exceed 6 doses in 24 hours•a special measuring device should be used to give an accurate dose of this product to children under 6 years of age•giving a higher dose than recommended by a doctor can result in serious side effects for a childadults and children 12 years and over10 mL (2 teaspoonfuls)children 6 to under 12 years of age5 mL (1 teaspoonful)children under 6 years of ageConsult a doctor. This formulation utilizes a solution delivery system. Marketed by Cardinal Health 107, Llc, this product is identified by NDC 55154-5791 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 995868 - codeine phosphate 10 MG / guaiFENesin 100 MG in 5 mL Oral Solution
- RxCUI: 995868 - codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution
- RxCUI: 995868 - codeine phosphate 10 MG / guaifenesin 100 MG per 5 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 55154 - Cardinal Health 107, Llc
- 55154-5791 - Guaifenesin And Codeine Phosphate
- 55154-5791-5 - 5 CUP, UNIT-DOSE in 1 BAG / 5 mL in 1 CUP, UNIT-DOSE
- 55154-5791 - Guaifenesin And Codeine Phosphate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55154-5791-5 identifies a specific commercial package of 5 cup, unit-dose in 1 bag / 5 ml in 1 cup, unit-dose of Guaifenesin And Codeine Phosphate, a human over the counter drug labeled by Cardinal Health 107, Llc. This solution is formulated for oral use and contains codeine phosphate; guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cardinal Health 107, Llc on June 27, 2023. The current certification is valid through December 31, 2026.
How is this Cardinal Health 107, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55154579105. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.